LEXURE for Post-Stroke Aphasia
A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 116 participants.
Also called NCT07570264
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 116 participants
- Sponsor
- Nunaps Inc
- Registry
-
NCT07570264
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- South Korea
- Registry status
- Recruiting
Technical summary
Registry record NCT07570264. Randomized; single masking; primary purpose treatment. Start 2026-04-16 (actual); primary completion 2026-12-30 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- LEXURE for Post-Stroke Aphasia
- Condition
- Aphasia
- Intervention (Device)
- LEXURE
- Intervention (Behavioral)
- Workbook
- Lead sponsor
- Nunaps Inc
Record details
- Record id
cardio:ct-nct07570264- Content hash
9d594d705f82c35974878c2aaabe4ec769c9acce88f602abeaf13334861531ef